Attached files

file filename
EX-31.2 - EX-31.2 - Axsome Therapeutics, Inc.axsm-20200930xex31d2.htm
EX-10.2 - EX-10.2 - Axsome Therapeutics, Inc.axsm-20200930xex10d2.htm
10-Q/A - 10-Q/A - Axsome Therapeutics, Inc.axsm-20200930x10qa.htm

Exhibit 31.1

CERTIFICATION OF PERIODIC REPORT

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Herriot Tabuteau, M.D., certify that:

1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q of Axsome Therapeutics, Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: November 6, 2020

/s/ Herriot Tabuteau, M.D.

Herriot Tabuteau, M.D.
Chief Executive Officer
(Principal Executive Officer)